References
1. Yart A, Edouard T. Noonan syndrome: an update on growth and
development. Curr Opin Endocrinol Diabetes Obes. 2018 Feb; 25(1):67-73.
2. Bhambhani V, Muenke M. Noonan syndrome. Am Fam Physician. 2014 Jan 1;
89(1):37-43.
3. Roberts AE, Allanson JE, Tartaglia M, Gelb BD. Noonan syndrome.
Lancet. 2013 Jan 26; 381(9863):333-42.
4. Ziegler A, Loundon N, Jonard L, Cavé H, Baujat G, Gherbi S,
Couloigner V, Marlin S. Noonan Syndrome: An Underestimated Cause of
Severe to Profound Sensorineural Hearing Impairment. Which Clues to
Suspect the Diagnosis? Otol Neurotol. 2017 Sep; 38(8):1081-1084.
5. Novelli PM, Chan EG, Frazier AA, Villa Sanchez M. Interventional
Therapies for Thoracic Duct Injury and Intractable Chylothorax.J Thorac
Imaging. 2019 Jul; 34(4):258-265.
6. Shimakawa T, Naritaka Y, Miyazawa M, Asaka S, Shimazaki A, Yamaguchi
K, Yokomizo H, Yoshimatsu K, Shiozawa S, Katsube T. Lymphangiography Was
Useful in Postoperative Intractable Chylothorax after Surgery for
Esophageal Cancer: A Case Report. J Nippon Med Sch. 2017; 84(6):268-273.
7. Turner AM. Noonan syndrome. J Paediatr Child Health. 2014 Oct;
50(10):E14-20.
8. van der Burgt I. Noonan syndrome. Orphanet J Rare Dis. 2007 Jan 14;
2:4.
9. Castel P, Cheng A, Cuevas-Navarro A, Everman DB, Papageorge AG,
Simanshu DK, Tankka A, Galeas J, Urisman A, McCormick F. RIT1
oncoproteins escape LZTR1-mediated proteolysis. Science. 2019 Mar 15;
363(6432):1226-1230.
10. Kouz K, Lissewski C, Spranger S, Mitter D, Riess A, Lopez-Gonzalez
V, Lüttgen S, Aydin H, von Deimling F, Evers C, Hahn A, Hempel M, Issa
U, Kahlert AK, Lieb A, Villavicencio-Lorini P, Ballesta-Martinez MJ,
Nampoothiri S, Ovens-Raeder A, Puchmajerová A, Satanovskij R, Seidel H,
Unkelbach S, Zabel B, Kutsche K, Zenker M. Genotype and phenotype in
patients with Noonan syndrome and a RIT1 mutation. Genet Med. 2016 Dec;
18(12):1226-1234.
11. Cavé H, Caye A, Ghedira N, Capri Y, Pouvreau N, Fillot N, Trimouille
A, Vignal C, Fenneteau O, Alembik Y, Alessandri JL, Blanchet P, Boute O,
Bouvagnet P, David A, Dieux Coeslier A, Doray B, Dulac O, Drouin-Garraud
V, Gérard M, Héron D, Isidor B, Lacombe D, Lyonnet S, Perrin L, Rio M,
Roume J, Sauvion S, Toutain A, Vincent-Delorme C, Willems M, Baumann C,
Verloes A. Mutations in RIT1 cause Noonan syndrome with possible
juvenile myelomonocytic leukemia but are not involved in acute
lymphoblastic leukemia. Eur J Hum Genet. 2016 Aug; 24(8):1124-31.
12. Aoki Y, Niihori T, Inoue S, Matsubara Y. Recent advances in
RASopathies. J Hum Genet. 2016 Jan; 61(1):33-9.
13. Aoki Y, Niihori T, Banjo T, Okamoto N, Mizuno S, Kurosawa K, Ogata
T, Takada F, Yano M, Ando T, Hoshika T, Barnett C, Ohashi H, Kawame H,
Hasegawa T, Okutani T, Nagashima T, Hasegawa S, Funayama R, Nagashima T,
Nakayama K, Inoue S, Watanabe Y, Ogura T, Matsubara Y. Gain-of-function
mutations in RIT1 cause Noonan syndrome, a RAS/MAPK pathway syndrome. Am
J Hum Genet. 2013 Jul 11; 93(1):173-80.
14. Niihori T, Nagai K, Fujita A, Ohashi H, Okamoto N, Okada S, Harada
A, Kihara H, Arbogast T, Funayama R, Shirota M, Nakayama K, Abe T, Inoue
SI, Tsai IC, Matsumoto N, Davis EE, Katsanis N, Aoki Y.
Germline-Activating RRAS2 Mutations Cause Noonan Syndrome. Am J Hum
Genet. 2019 Jun 6; 104(6):1233-1240.
15. Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med.
2017 Aug; 22(4):234-239.
16. Tutor JD. Chylothorax in infants and children. Pediatrics. 2014 Apr;
133(4):722-33.
17. García J, Alemán C, Jáuregui A, Vázquez A, Persiva Ó, Fernández de
Sevilla T. Chylothorax in Adults. Characteristics of 17 Patients and a
Review of the Literature. Arch Bronc Chylothorax in Adults.
Characteristics of 17 Patients and a Review of the Literature. Arch
Bronconeumol. 2017 Jul; 53(7):407-408.